Scienture Holdings, Inc. (SCNX) Revenue History
Annual and quarterly revenue from 2006 to present
SCNX Revenue Over Time (2006–2025)
SCNX Revenue Growth History
8 of 12 years with positive growth- FY2006 revenue growth
- N/A
- FY2007 revenue growth
- N/A
- FY2008 revenue growth
- N/A
- FY2013 revenue growth
- N/A
- FY2014 revenue growth
- +56.5%
- FY2015 revenue growth
- +94.7%
- FY2016 revenue growth
- -14.8%
- FY2017 revenue growth
- +18.1%
- FY2018 revenue growth
- +30.7%
- FY2019 revenue growth
- +94.1%
- FY2020 revenue growth
- +130.3%
- FY2021 revenue growth
- -42.2%
- FY2022 revenue growth
- +3.6%
- FY2023 revenue growth
- -86.7%
- FY2024 revenue growth
- -90.0%
- FY2025 revenue growth
- +215.9%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $56K | +449.1% |
| Q4 2025 | $-168,699 | -417.8% |
| Q3 2025 | $590K | +809.7% |
| Q2 2025 | $0 | -100.0% |
| Q1 2025 | $10K | — |
| Q4 2024 | $53K | -97.7% |
| Q3 2024 | $65K | -83.5% |
| Q2 2024 | $19K | -94.9% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown
SCNX's revenue distribution by segment and geography
By Geography
SCNX Revenue Analysis (2006–2025)
Current Revenue & Growth
As of June 21, 2026, Scienture Holdings, Inc. (SCNX) generated trailing twelve-month (TTM) revenue of $477,676, reflecting explosive growth of +449.1% year-over-year. The most recent quarter (Q1 2026) recorded $56,325 in revenue
Historical Growth Trajectory
SCNX's 5-year compound annual growth rate (CAGR) stands at -52.1%, indicating revenue contraction over this period. The 3-year CAGR of -65.2% is below the 5-year average, signalling a growth deceleration in recent years. Scienture Holdings, Inc.'s highest annual revenue of $17.1 million was recorded in 2020.
Peer Comparison
Compared to Healthcare sector peers — including TARS (+129.0% YoY), and ETON (+79.9% YoY) — SCNX has outperformed the peer group in revenue growth. Compare SCNX vs TARS →
SCNX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SCNXCurrent | $477,676 | +449.1% | -52.1% | -3763.8% | |
 TARS | $451M | +129.0% | - | -15.7% | |
 ETON | $80M | +79.9% | +359.6% | 0.1% |
SCNX Historical Revenue Data (2006–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $432K | +215.9% | $331K | 76.8% | $-16,244,792 | -3763.8% |
| 2024 | $137K | -90.0% | $6K | 4.4% | $-14,701,015 | -10758.7% |
| 2023 | $1.4M | -86.7% | $49K | 3.6% | $-4,396,451 | -322.4% |
| 2022 | $10.3M | +3.6% | $5.5M | 53.8% | $-2,915,969 | -28.4% |
| 2021 | $9.9M | -42.2% | $4.7M | 48.0% | $-5,292,293 | -53.5% |
| 2020 | $17.1M | +130.3% | $5.7M | 33.3% | $-2,506,662 | -14.6% |
| 2019 | $7.4M | +94.1% | $4.9M | 65.5% | $125K | 1.7% |
| 2018 | $3.8M | +30.7% | $3.4M | 88.3% | $-87,616 | -2.3% |
| 2017 | $2.9M | +18.1% | $2.9M | 100.0% | $395K | 13.5% |
| 2016 | $2.5M | -14.8% | $2.5M | 99.3% | $-1,007,279 | -40.6% |
| 2015 | $2.9M | +94.7% | $2.7M | 93.5% | $-137,070 | -4.7% |
| 2014 | $1.5M | +56.5% | $1.1M | 70.6% | $-1,431,472 | -95.7% |
| 2013 | $956K | - | $12K | 1.2% | $-2,084,004 | -218.0% |
| 2008 | $0 | - | $0 | - | $-28,497,000 | - |
| 2007 | $0 | - | $0 | - | $-28,186 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
20+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SCNX — Frequently Asked Questions
Quick answers to the most common questions about buying SCNX stock.
Is SCNX's revenue growth accelerating or slowing?
SCNX revenue growth is accelerating. TTM revenue reached $477676.00, up +449.1% year-over-year — ahead of the 5-year CAGR of -52.1%. This indicates the business is expanding faster than its historical baseline.
What is SCNX's revenue history from 2006 to 2026?
Scienture Holdings, Inc. (SCNX) revenue history spans 2006 to 2026. TTM revenue as of 2026 is $477676.00, growing at +449.1% YoY. The 5-year CAGR is -52.1%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is SCNX's long-term revenue growth rate (CAGR)?
Scienture Holdings, Inc.'s 5-year revenue CAGR of -52.1% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +449.1% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for SCNX.
Why does SCNX's quarterly revenue fluctuate?
SCNX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Scienture Holdings, Inc.'s revenue data from 2006 to 2026 shows full historical quarterly detail on this page.
How is SCNX's revenue distributed by segment?
SCNX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does SCNX's revenue compare to industry peers?
Scienture Holdings, Inc. (SCNX) with TTM revenue of $477676.00 and +449.1% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.